Literature DB >> 1133758

Effect of surfactants on absorption through membranes IV: effects of dioctyl sodium sulfosuccinate on absorption of a poorly absorbable drug, phenolsulfonphthalein, in humans.

N Khalafallah, M W Gouda, S A Khalil.   

Abstract

To explore the effect of dioctyl sodium sulfosuccinate on drug absorption in humans, the urinary excretion of a poorly absorbable drug, phenolsulfonphthalein, administered in solution with and without the surfactant was determined. Coadministration of a therapeutic dose of the surfactant with the drug solution resulted in a significant increase in the initial rate of absorption. A small increase in the extent of absorption was also observed. Pretreatment with the surfactant for 6 nights, followed by administration of the drug on the 7th day, did not significantly change the rate of extent of absorption. The surfactant is thought to have a direct effect on the GI membrane, resulting in a temporary change in its permeability. This effect appears to be reversible after a few hours.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1133758     DOI: 10.1002/jps.2600640621

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Preparation and physicochemical characterization of dioctyl sodium sulfosuccinate (aerosol OT) microemulsion for oral drug delivery.

Authors:  Hanan M El-Laithy
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

2.  Gastric emptying and intestinal appearance of nonabsorbable drugs phenol red and paromomycin in human subjects: A multi-compartment stomach approach.

Authors:  Paulo Paixão; Marival Bermejo; Bart Hens; Yasuhiro Tsume; Joseph Dickens; Kerby Shedden; Niloufar Salehi; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Jeffrey Wysocki; Bo Wen; Allen Lee; Ann Frances; Gregory E Amidon; Alex Yu; Gail Benninghoff; Raimar Löbenberg; Arjang Talattof; Duxin Sun; Gordon L Amidon
Journal:  Eur J Pharm Biopharm       Date:  2018-05-29       Impact factor: 5.571

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.